Refining Therapy in Patients with HER2-Positive Breast Cancer with Central Nervous System Metastasis.

Breast care (Basel, Switzerland)(2022)

引用 0|浏览6
暂无评分
摘要
The treatment paradigm for patients with HER2+ MBC has changed. Local therapies play an important role, but accumulating evidence on the intracranial activity and clinical benefit of anti-HER2 targeting therapies might lead to a shift in the paradigm on treating BM in the next few years towards more widespread use of systemic therapy.
更多
查看译文
关键词
Anti-HER2-targeted therapy,Brain metastasis,Central nervous system metastasis,Human epidermal growth factor receptor-type 2-positive breast cancer,Leptomeningeal carcinomatosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要